Assessing tumor response to therapy
WA Weber - Journal of nuclear medicine, 2009 - Soc Nuclear Med
… understood, modulate the sensitivity of tumor cells to specific targeted drugs. These factors
… to assess the responsiveness of tumor cells to therapy. Gene expression profiling using …
… to assess the responsiveness of tumor cells to therapy. Gene expression profiling using …
[HTML][HTML] Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
DA Quigley, V Kristensen - Molecular oncology, 2015 - Elsevier
… cell populations that promote tumor escape from immune surveillance and metastasis.
Therapeutic approaches that kill tumor cells … are becoming an established therapeutic option, but …
Therapeutic approaches that kill tumor cells … are becoming an established therapeutic option, but …
Emerging role of tumor cell plasticity in modifying therapeutic response
… therapeutic response has considerably increased. This expanded knowledge of tumor
cell plasticity contributes to developing novel therapeutic strategies or combination therapy …
cell plasticity contributes to developing novel therapeutic strategies or combination therapy …
Tumor microenvironment and therapeutic response
T Wu, Y Dai - Cancer letters, 2017 - Elsevier
… tumor cells to stromal fibroblasts or to components of the extracellular matrix can also blunt
therapeutic response… on how the TME regulates therapeutic response and discuss potential …
therapeutic response… on how the TME regulates therapeutic response and discuss potential …
Cancer cell plasticity: Impact on tumor progression and therapy response
V da Silva-Diz, L Lorenzo-Sanz… - Seminars in cancer …, 2018 - Elsevier
… cell states, the mechanisms governing cell plasticity and their impact on tumor progression,
metastasis and therapy response… Understanding the mechanisms involved in cancer cell …
metastasis and therapy response… Understanding the mechanisms involved in cancer cell …
Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
CM Coughlin, KE Salhany, MS Gee, DC LaTemple… - Immunity, 1998 - cell.com
… for their activity against tumors. We undertook the current study to examine how tumor cell
responses to IFNγ affect the antitumor activity of IL-12. IFNγ stimulates cells by binding to a …
responses to IFNγ affect the antitumor activity of IL-12. IFNγ stimulates cells by binding to a …
Immune response against dying tumor cells
L Zitvogel, N Casares, MO Péquignot… - Advances in …, 2004 - books.google.com
… of tumor cell death and/or the immune system can be manipulated so dying tumor cells …
as part of a combination therapy, eg, CD40L), we might achieve effective T-cell activation. …
as part of a combination therapy, eg, CD40L), we might achieve effective T-cell activation. …
Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy
… in tumor cells as an adaptive response to the hypoxia caused by antiangiogenic therapy can
be expanded to determine the effect of hypoxia on cells in the tumor microenvironment. For …
be expanded to determine the effect of hypoxia on cells in the tumor microenvironment. For …
Technologies for deriving primary tumor cells for use in personalized cancer therapy
… and cons of different methods for primary tumor cell culture. … cons of different methods for
primary tumor cell culture. Furthermore, … primary tumor cells redefine cancer therapies with high …
primary tumor cell culture. Furthermore, … primary tumor cells redefine cancer therapies with high …
Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
V Müller, N Stahmann, S Riethdorf, T Rau… - Clinical Cancer …, 2005 - AACR
… circulating tumor cell detection as a tool to monitor therapy in … about the frequency of circulating
tumor cells in patients with … characteristics of circulating tumor cells are largely unknown. …
tumor cells in patients with … characteristics of circulating tumor cells are largely unknown. …